{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 66: Mark Abelson, Founder of Ora Clinical","slug":"episode-66-mark-abelson-founder-of-ora-clinical","published_at":"2025-12-16T10:20:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-66-mark-abelson-founder-of-ora-clinical","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-66-mark-abelson-founder-of-ora-clinical","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2290812/c1e-o3p3nb28qg5im2roj-jpn5g0rwi7p3-bkrcrf.mp3","summary":"Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer. We'll be discussing exploratory endpoints, what to learn from failed trails, and essential factors in choosing a clinical site location. Listen today!","meta_description":"Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark A…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2607,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-66-mark-abelson-founder-of-ora-clinical/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-66-mark-abelson-founder-of-ora-clinical.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}